Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Palmatine is a natural isoquinoline alkaloid of the protoberberine class found in several medicinal plants such as Phellodendron amurense and Coptis chinensis. It has a wide spectrum of pharmacological effects including anti-cancer (notably via cell cycle arrest and apoptosis), anti-oxidant activity (scavenging free radicals), anti-inflammatory effects (modulating inflammatory mediators), neuroprotection (potential cognitive enhancement and MAO inhibition), antibacterial and antiviral properties. Palmatine is used mainly in traditional Chinese medicine for gastrointestinal tract infections and other infectious or inflammatory conditions. Its mechanism of action involves multiple molecular targets including DNA intercalation leading to cytotoxicity at higher concentrations; it also modulates metabolic enzymes in the liver. The main metabolic pathways are glucuronidation and sulfation[1][3][4][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on palmatine.